Company Filing History:
2 out of 10 
2 out of 4 Years Active: 2023-2025
Title: The Innovative Contributions of Inventor María Ochoa De Olza
Introduction
María Ochoa De Olza is a notable inventor based in Sant Cugat del Vallès, Spain. He has made significant contributions to the field of cancer research, particularly in the area of biomarkers for cancer detection and treatment response. With a total of 2 patents, his work has the potential to impact cancer diagnosis and monitoring significantly.
Latest Patents
One of his latest patents is focused on PD-ECGF as a biomarker of cancer. This invention is related to predicting cancer detection, diagnosis, monitoring, and the prediction of response to treatment. Specifically, it involves the use of platelet-derived endothelial cell growth factor (PD-ECGF) levels as a potential value in monitoring disease evolution and predicting response to anti-angiogenic treatment. This innovative approach aims to enhance the accuracy of cancer treatment and improve patient outcomes.
Career Highlights
Throughout his career, María Ochoa De Olza has worked with esteemed organizations such as the Catalan Institute of Oncology and the Bellvitge Biomedical Research Institute. His experience in these institutions has allowed him to develop and refine his research in cancer biomarkers, contributing to advancements in the medical field.
Collaborations
He has collaborated with notable colleagues, including Oriol Casanovas Casanovas and Gabriela Jiménez Valerio. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in cancer research.
Conclusion
María Ochoa De Olza's contributions to cancer research through his patents and collaborations highlight the importance of innovation in the medical field. His work continues to pave the way for advancements in cancer detection and treatment, ultimately benefiting patients worldwide.